Modeling risk and progression in chronic stomach lining disease
Part of Digestive system clinical trials.
This study looks at people with chronic atrophic gastritis to estimate who may be at higher risk of stomach cancer over time. It collects symptom and medical data, plus blood and tissue samples, to build prediction models that may improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 18 and 75 years old.
- Your diagnosis of chronic atrophic gastritis was confirmed by an upper endoscopy (a scope of the upper stomach).
- You are willing to provide blood and stomach tissue samples during the study period.
- You can answer questions and share information on time during follow-ups.
- You agree to sign the informed consent form and participate as planned.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses endoscopy findings to predict if high-risk patients will develop stomach cancer or precancerous changes. It aims to improve follow-up care for people with signs of infection or stomach lining thinning.
This trial studies whether a condition called atrophic gastritis (thinning of the stomach lining) can help predict who is more likely to develop stomach cancer. It may help with early detection and prevention.
This trial looks at adults with stomach lining changes—either atrophic gastritis or intestinal metaplasia—and studies how to predict who may be at risk for stomach cancer. It may help earlier identification and closer monitoring for people with these conditions.
This study collects health information from people at different stages of stomach cancer risk, including those with precancerous changes, healthy individuals, and those with early stomach cancer. The goal is to better understand and prevent stomach cancer.
This study looks at people with certain stomach symptoms or precancer risk factors when they get a camera test of the upper digestive tract (endoscopy). The goal is to learn how to better detect and evaluate stomach precancer conditions early, which may help guide treatment or follow-up.
This study follows patients with pre-cancerous stomach conditions to learn more about how they progress. By collecting health information over time, researchers hope to improve early detection and treatment of stomach cancer.
Hear when a new Risk Assessment of Chronic Atrophic Gastritis Malignant Transformation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.